Two stage study of wound microorganisms affecting burns and plastic surgery inpatients

Journal of Burn Care and Research

Volumn 29, Issue 6, 2008, Pages 927-932

  Miranda, Benjamin H ^a,b   Ali, Syed N ^a   Jeffery, Steven L A ^a   Thomas, Sunil S ^a  

^a SELLY OAK HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; CEFALEXIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; ERYTHROMYCIN; FLUCLOXACILLIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; MEROPENEM; NALIDIXIC ACID; NITROFURANTOIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARMY; ARTICLE; BACTERIAL FLORA; BACTERIUM CULTURE; BURN; BURN PATIENT; BURN UNIT; CHI SQUARE TEST; CONTROLLED STUDY; ENTEROCOCCUS; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROORGANISM; NONHUMAN; PREVALENCE; PSEUDOMONAS; RETROSPECTIVE STUDY; STAPHYLOCOCCUS; STATISTICAL SIGNIFICANCE; SURGICAL PATIENT; WOUND INFECTION;

BACTERIAL INFECTIONS; BURN UNITS; BURNS; CHI-SQUARE DISTRIBUTION; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; RETROSPECTIVE STUDIES; SURGERY, PLASTIC;

EID: 57149119083     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e31818ba15f     Document Type: Article

References (15)

1. Wasserman D. Systemic complications of extended burns. Ann Chir Plast Esthet 2001;46:196-209.
2. Astagneau P, Rioux C, Golliot F, Bruker G. INCISO Network Study Group. Morbidity and mortality associated with surgical site infections: results from the 1997-1999 INCISO surveillance. J Hosp Infect 2001;48:267-74.
3. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990 to May 1999, issued June 1999. Am J Infect Control 1999;27:520-32.
4. Poulsen KB, Bremmelgaark A, Sorenson AI, Raahave D, Petersen JV. Estimated costs of postoperative wound infections. A case-control study of marginal hospital and social security costs. Epidemiol Infect 1994;113:283-95.
5. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis 2003;9:196-203.
6. Vindenes H, Bjerknes R. Microbial colonization of large wounds. Burns 1995;21:575-9.
7. Ressner RA, Murray CK, Griffith ME, Rasnake MS, Hospenthal DR, Wolf SE. Outcomes of bacteremia in burn patients involved in combat operations overseas. J Am Coll Surg 2008;206:439-44.
8. Barret JP, Herndon DN. Effects of burn wound excision on bacterial colonization and invasion. Plast Reconstr Surg 2003;111:744-50; discussion 751-2.
9. Baker RH, Townley WA, McKeon S, Linge C, Vijh V. Retrospective study of the association between hypertrophic burn scarring and bacterial colonization. J Burn Care Res 2007;28:152-6.
10. Centers for Disease Control and Prevention (CDC). Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly Rep 2004;53: 1063-6.
11. Petersen K, Riddle MS, Danko JR, et al. Trauma-related infections in battlefield casualties from Iraq. Ann Surg 2007; 245:803-11.
12. Heo ST, Peck KR, Ryu SY, et al. Analysis of methicillin resistance among Staphylococcus aureus blood isolates in an emergency department. J Korean Med Sci 2007;22:682-6.
13. Shorr AF. Epidemiology and economic impact of methicillinresistant Staphylococcus aureus. review and analysis of the literature. Pharmacoeconomics 2007;25:751-68.
14. Lee YT, Lin JC, Wang NC, Peng MY, Chang FY. Necrotizing fasciitis in a medical center in northern Taiwan: emergence of methicillin-resistant Staphylococcus aureus in the community. J Microbiol Immunol Infect 2007;40:335-41.
15. Ministry of Health, New Zealand. Methicillin-resistant Staphylococcus aureus (MRSA) in New Zealand. Wellington, New Zealand: Ministry of Health, 2002. p. 1-65; available from http://www.moh.govt.nz/cd/mrsa.